Jardine Matheson stock hits 52-week high on SGX after fresh buyback filing
27 January 2026
1 min read

Jardine Matheson stock hits 52-week high on SGX after fresh buyback filing

Singapore, Jan 27, 2026, 15:17 SGT — Regular session

Shares of Jardine Matheson Holdings Limited climbed 2.5% to $76.64 Tuesday afternoon in Singapore, hitting a 52-week peak amid increased action in the U.S. dollar counter. The stock gained $1.83 from Monday’s close of $74.81. 1

The move comes a day after the group announced another share repurchase, where it buys back its own stock and cancels the shares, cutting the total share count. A Singapore Exchange filing revealed Jardine Matheson repurchased 50,000 ordinary shares on Monday at $74.7185 each, costing about $3.7 million. 2

Singapore stocks showed strength, with the Straits Times Index climbing past 4,900 to reach a new peak of 4,912.46 in early trading, The Business Times reports. Investors are gearing up for a heavy week on the central-bank front, ahead of the U.S. Federal Reserve’s Jan. 27-28 meeting and the Monetary Authority of Singapore’s policy update slated for Jan. 29. 3

In Singapore, the MAS review carries weight similar to the Fed’s moves. Out of 16 analysts surveyed by Reuters, 15 predict MAS will hold policy steady on Thursday. Edward Lee, chief economist at Standard Chartered, noted there’s “no urgency to act” right now. 4

The Federal Reserve is widely expected to keep interest rates unchanged at 3.50%-3.75% when its meeting wraps up on Wednesday, according to Reuters. Michael Pearce, chief U.S. economist at Oxford Economics, described the near-term outlook as “benign” in a note Reuters cited. 5

Unlike many central banks, Singapore’s MAS doesn’t set domestic interest rates directly. Instead, it guides policy by adjusting the exchange-rate band of the Singapore dollar — the S$NEER, a trade-weighted currency index — allowing the currency to fluctuate within a secret range and intervening only when it drifts beyond that. 6

Jardine Matheson serves as the listed holding company for the Jardines group, managing a diverse portfolio that includes Indonesia’s Astra, retailer DFI, property landlord Hongkong Land, and hotel operator Mandarin Oriental. This variety makes the stock vulnerable to changes in consumer demand, property market trends, and fluctuations in Asian currencies. 7

Incorporated in Bermuda, the company’s main listing is in London, while it also holds secondary listings in Bermuda and Singapore, its investor relations page shows. 8

The buyback news by itself might not be enough to lift the stock if investors grow cautious. A hawkish Fed move or any change in MAS’s policy that rattles currency and interest rate forecasts could dampen appetite for cyclicals and conglomerates, even as share repurchases continue.

Investors now turn to Wednesday’s Fed decision, with MAS’s monetary policy statement due Thursday. Both events could shake up Singapore equities and influence the next move in Jardine Matheson shares.

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
UOL Group stock price jumps 7% after JPMorgan lifts target — SGX:U14 in focus
Previous Story

UOL Group stock price jumps 7% after JPMorgan lifts target — SGX:U14 in focus

Seatrium share price slips again as Singapore market climbs — what investors are watching
Next Story

Seatrium share price slips again as Singapore market climbs — what investors are watching

Go toTop